BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 12584269)

  • 1. Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat.
    Nielsen FT; Ottosen P; Starklint H; Dieperink H
    Nephrol Dial Transplant; 2003 Mar; 18(3):491-6. PubMed ID: 12584269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
    Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
    Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired glomerular and tubular function as a short-term effect of sirolimus treatment in the rat.
    Nielsen FT; Starklint H; Dieperink H
    Am J Nephrol; 2005; 25(4):411-6. PubMed ID: 16088082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effects of sirolimus with cyclosporine and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood.
    Barten MJ; Streit F; Boeger M; Dhein S; Tarnok A; Shipkova M; Armstrong VW; Mohr FW; Oellerich M; Gummert JF
    Transplantation; 2004 Apr; 77(8):1154-62. PubMed ID: 15114077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
    Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
    Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of low dose cyclosporine and sirolimus on hepatic drug metabolism in the rat1.
    Bai S; Brunner LJ; Stepkowski SM; Napoli KL; Kahan BD
    Transplantation; 2001 Jun; 71(11):1585-92. PubMed ID: 11435969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal function.
    Russ G; Segoloni G; Oberbauer R; Legendre C; Mota A; Eris J; Grinyó JM; Friend P; Lawen J; Hartmann A; Schena FP; Lelong M; Burke JT; Neylan JF;
    Transplantation; 2005 Nov; 80(9):1204-11. PubMed ID: 16314787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506.
    Andoh TF; Burdmann EA; Fransechini N; Houghton DC; Bennett WM
    Kidney Int; 1996 Oct; 50(4):1110-7. PubMed ID: 8887267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive treatment and progression of histologic lesions in kidney allografts.
    Morales JM
    Kidney Int Suppl; 2005 Dec; (99):S124-30. PubMed ID: 16336565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus increases transforming growth factor-beta1 expression and potentiates chronic cyclosporine nephrotoxicity.
    Shihab FS; Bennett WM; Yi H; Choi SO; Andoh TF
    Kidney Int; 2004 Apr; 65(4):1262-71. PubMed ID: 15086465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Everolimus and sirolimus in combination with cyclosporine have different effects on renal metabolism in the rat.
    Bohra R; Schöning W; Klawitter J; Brunner N; Schmitz V; Shokati T; Lawrence R; Arbelaez MF; Schniedewind B; Christians U; Klawitter J
    PLoS One; 2012; 7(10):e48063. PubMed ID: 23118926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cyclosporine, tacrolimus and sirolimus on vascular changes related to immune response.
    Rigol M; Solanes N; Sionis A; Gálvez C; Martorell J; Rojo I; Brunet M; Ramírez J; Roqué M; Roig E; Pérez-Villa F; Barquín L; Pomar JL; Sanz G; Heras M
    J Heart Lung Transplant; 2008 Apr; 27(4):416-22. PubMed ID: 18374878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional haemodynamic effects of cyclosporine A, tacrolimus and sirolimus in conscious rats.
    Gardiner SM; March JE; Kemp PA; Fallgren B; Bennett T
    Br J Pharmacol; 2004 Feb; 141(4):634-43. PubMed ID: 14744807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of early and late conversion of sirolimus in experimental model of chronic cyclosporine nephropathy.
    Kim JY; Ghee JY; Lim SW; Piao SG; Chung BH; Yoon HE; Hwang HS; Choi BS; Kim J; Yang CW
    J Korean Med Sci; 2012 Feb; 27(2):160-9. PubMed ID: 22323863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sirolimus alone or in combination with cyclosporine A on renal ischemia/reperfusion injury.
    Pereira BJ; Castro I; Burdmann EA; Malheiros DM; Yu L
    Braz J Med Biol Res; 2010 Aug; 43(8):737-44. PubMed ID: 20549136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressant use without bone loss--implications for bone loss after transplantation.
    Goodman GR; Dissanayake IR; Sodam BR; Gorodetsky E; Lu J; Ma YF; Jee WS; Epstein S
    J Bone Miner Res; 2001 Jan; 16(1):72-8. PubMed ID: 11149492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study.
    Ekberg H; Bernasconi C; Nöldeke J; Yussim A; Mjörnstedt L; Erken U; Ketteler M; Navrátil P
    Nephrol Dial Transplant; 2010 Jun; 25(6):2004-10. PubMed ID: 20106825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug interaction between cyclosporine and mTOR inhibitors in experimental model of chronic cyclosporine nephrotoxicity and pancreatic islet dysfunction.
    Piao SG; Bae SK; Lim SW; Song JH; Chung BH; Choi BS; Yang CW
    Transplantation; 2012 Feb; 93(4):383-9. PubMed ID: 22267156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.